APA (7th ed.) Citation

Zattarin, E., Taglialatela, I., Lobefaro, R., Leporati, R., Fucà, G., Ligorio, F., . . . Vernieri, C. (2023). Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities. Critical reviews in oncology/hematology, 190, 104109. https://doi.org/10.1016/j.critrevonc.2023.104109

Chicago Style (17th ed.) Citation

Zattarin, Emma, et al. "Breast Cancers Arising in Subjects with Germline BRCA1 or BRCA2 Mutations: Different Biological and Clinical Entities with Potentially Diverse Therapeutic Opportunities." Critical Reviews in Oncology/hematology 190 (2023): 104109. https://doi.org/10.1016/j.critrevonc.2023.104109.

MLA (9th ed.) Citation

Zattarin, Emma, et al. "Breast Cancers Arising in Subjects with Germline BRCA1 or BRCA2 Mutations: Different Biological and Clinical Entities with Potentially Diverse Therapeutic Opportunities." Critical Reviews in Oncology/hematology, vol. 190, 2023, p. 104109, https://doi.org/10.1016/j.critrevonc.2023.104109.